Human neonatal peripheral blood leukocytes demonstrate pathogen-specific coordinate expression of TLR2, TLR4/MD2, and MyD88 during bacterial infection in vivo

Pediatric Research

Volumn 68, Issue 6, 2010, Pages 479-483

  Zhang, Jin Ping ^a   Yang, Yi ^a   Levy, Ofer ^b   Chen, Chao ^a  

^a CHILDREN S HOSPITAL OF FUDAN UNIVERSITY   (China)

^b BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; MYELOID DIFFERENTIATION FACTOR 88; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4;

ARTICLE; BACTEREMIA; BACTERIAL INFECTION; CONTROLLED STUDY; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; GRANULOCYTE; HUMAN; HUMAN CELL; IN VIVO STUDY; INNATE IMMUNITY; LEUKOCYTE; MONOCYTE; NEWBORN; NEWBORN INFECTION; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

BACTERIAL INFECTIONS; FEMALE; GRANULOCYTES; HUMANS; IMMUNITY, INNATE; INFANT, NEWBORN; LEUKOCYTES; LYMPHOCYTE ANTIGEN 96; MONOCYTES; MYELOID DIFFERENTIATION FACTOR 88; PREGNANCY; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4;

EID: 78649351618     PISSN: 00313998     EISSN: 15300447     Source Type: Journal    
DOI: 10.1203/PDR.0b013e3181f90810     Document Type: Article

References (37)

1. Levy O 2007 Innate Immunity of the human newborn: basic mechanisms and clinical correlates. Nat Rev Immunol 7:379-390
2. Medzhitov R 2007 Recognition of microorganisms and activation of the immune response. Nature 449:819-826
3. Jenkins KA, Mansell A 2010 TIR-containing adaptors in toll-like receptor signalling. Cytokine 49:237-244
4. Strunk T, Temming P, Gembruch U, Reiss I, Bucsky P, Schultz C 2004 Differential maturation of the innate immune response in human fetuses. Pediatr Res 56:219-226
5. Medzhitov R, Preston-Hurlburt P, Janeway CA Jr 1997 A human homologue of the Drosophila toll protein signals activation of adaptive immunity. Nature 388:394-397
6. Yamamoto M, Sato S, Hemmi H, Hoshino K, Kaisho T, Sanjo H, Takeuchiet O 2003 Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Science 301:640-643 (Pubitemid 36927946)
7. Underhill DM, Ozinsky A, Smith KD, Aderem A 1999 Toll-like receptor-2 mediates mycobacteria-induced proinflammatory signaling in macrophages. Proc Natl Acad Sci \USA 96:14459-14463
8. Poltorak A, He X, Smirnova I, Liu M-Y, Van Huffel C, Du X, Birdwell D, Alejos E, Silva M, Galanos C 1998 Defective LPS signaling in C3H/HeJ and C57BL/ 10ScCr mice: mutations in Tlr4 gene. Science 282:2085-2088
9. Dobrovolskaia MA, Vogel SN 2002 Toll receptors, CD14, and macrophage activation and deactivation by LPS. Microbes Infect 4:903-914
10. Nishitani C, Mitsuzawa H, Hyakushima N, Sano H, Matsushima N, Kuroki Y 2005 The toll-like receptor 4 region Glu24-Pro34 is critical for interaction with MD-2. Biochem Biophys Res Commun 328:586-590
11. Gioannini TL, Teghanemt A, Zhang D, Coussens NP, Dockstader W, Ramaswamy S, Weiss JP 2004 Isolation of an endotoxin-MD-2 complex that produces toll-like receptor 4-dependent cell activation at picomolar concentrations. Proc Natl Acad Sci \USA 101:4186-4191
12. O'Neill LA 2006 How toll-like receptors signal: what we know and what we don't know. Curr Opin Immunol 18:3-9
13. Lakhani SA, Bogue CW 2003 Toll-like receptor signaling in sepsis. Curr Opin Pediatr 15:278-282
14. Förster-Waldl E, Sadeghi K, Tamandl D, Gerhold B, Hallwirth U, Rohrmeister K, Hayde M, Prusa AR, Herkner K, Boltz-Nitulescu G, Pollak A, Spittler A 2005 Monocyte toll-like receptor 4 expression and LPS-induced cytokine production increase during gestational aging. Pediatr Res 58:121-124
15. Harju K, Glumoff V, Hallman M 2001 Ontogeny of toll-like receptors Tlr2 and Tlr4 in mice. Pediatr Res 49:81-83
16. Yan SR, Qing G, Byers DM, Stadnyk AW, Al-Hertani W, Bortolussi R 2004 Role of MyD88 in diminished tumor necrosis factor alpha production by newborn mononuclear cells in response to lipopolysaccharide. Infect Immun 72:1223-1229
17. Viemann D, Dubbel G, Schleifenbaum S, Harms E, Sorg C, Roth J 2005 Expression of toll-like receptors in neonatal sepsis. Pediatr Res 58:654-659
18. Henneke P, Osmers I, Bauer K, Lamping N, Versmold HT, Schumannet RR 2003 Impaired CD14-dependent and independent response of polymorphonuclear leukocytes in preterm infants. J Perinat Med 31:176-183
19. Qing G, Rajaraman K, Bortolussi R 1995 Diminished priming of neonatal polymor-phonuclear leukocytes by lipopolysaccharide is associated with reduced CD14 expression. Infect Immun 63:248-252
20. Levy E, Xanthou G, Petrakou E, Zacharioudaki V, Tsatsanis C, Fotopoulos S, Xanthou M 2009 Distinct roles of TLR4 and CD14 in LPS-induced inflammatory responses of neonates. Pediatr Res 66:179-184
21. Yerkovich ST, Wikström ME, Suriyaarachchi D, Prescott SL, Upham JW, Holt PG 2007 Postnatal development of monocyte cytokine responses to bacterial lipopoly-saccharide. Pediatr Res 62:547-552
22. Sadeghi K, Berger A, Langgartner M, Prusa AR, Hayde M, Herkner K, Pollak A, Forster-Waldl E 2007 Immaturity of infection control in preterm and term newborns is associated with impaired toll-like receptor signaling. J Infect Dis 195:296-302
23. Levy O, Zarember KA, Roy RM, Cywes C, Godowski PJ, Wessels MR 2004 Selective impairment of TLR-mediated innate immunity in human newborns: neonatal blood plasma reduces monocyte TNF-alpha induction by bacterial lipopeptides, lipopolysaccharide, and imiquimod, but preserves the response to R-848. J Immunol 173:4627-4634
24. Zhang JP, Chen C, Yang Y 2007 [Changes and clinical significance of toll-like receptor 2 and 4 expression in neonatal infections]. Zhonghua Er Ke Za Zhi 45:130-133
25. Orsi GB, d'Ettorre G, Panero A, Chiarini F, Vullo V, Venditti M 2009 Hospital-acquired infection surveillance in a neonatal intensive care unit. Am J Infect Control 37:201-203
26. Marsik C, Mayr F, Cardona F, Derhaschnig U, Wagner OF, Jilma B 2003 Endo-toxaemia modulates toll-like receptors on leucocytes in humans. Br J Haematol 121:653-656
27. Salomao R, Brunialti MK, Gomes NE, Mendes ME, Diaz RS, Komninakis S 2009 Toll-like receptor pathway signaling is differently regulated in neutrophils and peripheral mononuclear cells of patients with sepsis, severe sepsis, and septic shock. Crit Care Med 37:132-139
28. Wolfs TG, Dunn-Siegrist I, Van't Veer C, Hodin CM, Germeraad WT, Van Zoelen MA 2008 Increased release of sMD-2 during human endotoxemia and sepsis: a role for endothelial cells. Mol Immunol 45:3268-3277
29. Akashi S, Saitoh S, Wakabayashi Y, Kikuchi T, Takamura N, Nagai Y, Kusumoto Y, Fukase K, Kusumoto S, Adachi Y 2003 Lipopolysaccharide interaction with cell surface toll-like receptor 4-MD-2: higher affinity than that with MD-2 or CD14. J Exp Med 198:1035-1042
30. Akashi S, Shimazu R, Ogata H, Nagai Y, Takeda K, Kimoto M, Miyake K 2000 Cutting edge: cell surface expression and lipopolysaccharide signaling via the toll-like receptor 4-MD-2 complex on mouse peritoneal macrophages. J Immunol 164:3471-3475
31. Ishihara S, Rumi MA, Kadowaki Y, Kitamura T, Kosugi A, Kimoto M, Miyake K 2002 Essential role of MD-2 in LPS responsiveness and TLR4 distribution. Nat Immunol 3:667-672
32. Kawai T, Adachi O, Ogawa T, Takeda K, Akira S 1999 Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity 11:115-122
33. Ku CL, von Bernuth H, Picard C, Zhang SY, Chang HH, Yang K, Chrabieh M, Issekutz AC, Cunningham CK, Gallin J, Holland SM, Roifman C, Ehl S, Smart J, Tang M, Barrat FJ, Levy O, McDonald D, Day-Good NK, Miller R, Takada H, Hara T, Al-Hajjar S, Al-Ghonaium A, Speert D, Sanlaville D, Li X, Geissmann F, Vivier E, Maródi L, Garty BZ, Chapel H, Rodriguez-Gallego C, Bossuyt X, Abel L, Puel A, Casanova JL 2007 Selective predisposition to bacterial infections in IRAK-4-deficient children: IRAK-4-dependent TLRs are otherwise redundant in protective immunity. J Exp Med 204:2407-2422
34. von Bernuth H, Picard C, Jin Z, Pankla R, Xiao H, Ku CL, Chrabieh M, Mustapha IB, Ghandil P, Camcioglu Y, Vasconcelos J, Sirvent N, Guedes M, Vitor AB, Herrero-Mata MJ, Aróstegui JI, Rodrigo C, Alsina L, Ruiz-Ortiz E, Juan M, Fortuny C, Yagüe J, Antón J, Pascal M, Chang HH, Janniere L, Rose Y, Garty BZ, Chapel H, Issekutz A, Maródi L, Rodriguez-Gallego C, Banchereau J, Abel L, Li X, Chaussabel D, Puel A, Casanova JL 2008 Pyogenic bacterial infections in humans with MyD88 deficiency. Science 321:691-696
35. Akira S, Takeda K 2004 Toll-like receptor signalling. Nat Rev Immunol 4:499-511
36. Wynn JL, Scumpia PO, Winfield RD, Delano MJ, Kelly-Scumpia K, Barker T, Ungaro R, Levy O, Moldawer LL 2008 Defective innate immunity predisposes murine neonates to poor sepsis outcome but is reversed by TLR agonists. Blood 112:1750-1758
37. Wynn JL, Neu J, Moldawer LL, Levy O 2009 Potential of immunomodulatory agents for prevention and treatment of neonatal sepsis. J Perinatol 29:79-88